¼¼°èÀÇ µ¿¹° ¸ðµ¨ ½ÃÀå º¸°í¼­ : µ¿¹° À¯Çü, ±â¼ú, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ªº°(2024-2032³â)
Animal Model Market Report by Animal Type, Technology, Application, End User, and Region 2024-2032
»óǰÄÚµå : 1541112
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 139 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,156,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,541,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 6,927,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

µ¿¹° ¸ðµ¨ ½ÃÀå ¼¼°è ½ÃÀå ±Ô¸ð´Â 2023³â 18¾ï 1,010¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC ±×·ìÀº ½ÃÀåÀÌ 2032³â±îÁö 30¾ï 6,600¸¸ ´Þ·¯¿¡ À̸£¸ç, 2024³â°ú 2032³â »çÀÌ¿¡ 5.8%ÀÇ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

µ¿¹° ¸ðµ¨Àº ÀÇÇÐ ¿¬±¸ ¹× Á¶»ç¿¡ »ç¿ëµÇ´Â »ì¾ÆÀÖ´Â ºñÀΰ£ Á¾ÀÔ´Ï´Ù. Àΰ£ À¯ÀüÇÐ, ÇØºÎÇÐ, »ý¸®Çаú À¯»ç¼ºÀÌ ³ô±â ¶§¹®¿¡ ÀÚÁÖ ¼±Åõ˴ϴÙ. µ¿¹° ¸ðµ¨Àº Àΰ£¿¡°Ô ÇØ¸¦ ³¢Ä¡Áö ¾Ê°í Áúº´ ¿¹¹æ, Áø´Ü ¹× Ä¡·á¿¡ ´ëÇÑ Á¤º¸¸¦ ¾ò´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀϹÝÀûÀ¸·Î »ç¿ëµÇ´Â µ¿¹° ¸ðµ¨¿¡´Â ¼³Ä¡·ù, Áã, ¸¶¿ì½º, Áã, ±â´ÏÇDZ×, ÇܽºÅÍ µîÀÌ ÀÖ½À´Ï´Ù. ÇöÀç´Â ÀÔ¼öÇϱ⠽±°í, Ãë±ÞÀÌ ¿ëÀÌÇϰí, ºñ±³Àû Àú·ÅÇϱ⠶§¹®¿¡ ³Î¸® ¼±È£µÇ°í ÀÖ½À´Ï´Ù.

µ¿¹° ¸ðµ¨ ½ÃÀå µ¿Çâ :

ÇöÀç ¼¼°è¿¡¼­ °³ÀÎÈ­ ÀǾàǰÀÇ ¿ä±¸°¡ Áö¼ÓÀûÀ¸·Î ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. À̰ÍÀº ´Ù¿îÁõÈıº, Å©·Ðº´, À¯¹æ¾Ï, Ç÷¿ìº´°ú °°Àº À¯Àü¼º ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¬±¸ÀÚÀÇ ÀǾàǰ ÀüÀÓ»ó °³¹ß¿¡¼­ µ¿¹° ¸ðµ¨ÀÇ È°¿ë¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡´Â Áß¿äÇÑ ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ÀÌ ¿Ü¿¡µµ µ¿¹° ¸ðµ¨Àº ¼¼°èÀÇ »ý¹° ÀÇÇÐ ¿¬±¸, µ¶¹°ÇÐ, »ý¸®ÇÐ, ¾Ï ¿¬±¸, ½Å°æÇÐ ¿¬±¸, À¯ÀüÀÚ ¿¬±¸, ÀÌÁ¾ À̽Ŀ¡µµ ÀÌ¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ ½ÃÀåÀº À¯ÀüÀÚ ÆíÁý ±â¼úÀÎ CRISPR-Cas9ÀÇ µµÀÔ°ú °°Àº ¸¹Àº ±â¼úÀû Áøº¸¿¡ ÀÇÇØ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ±â¼úÀº ±¤¹üÀ§ÇÑ À¯ÀüÀÚ º¯ÇüÀ» µ¿¹ÝÇÑ µ¿¹° ¸ðµ¨ÀÇ Á¦ÀÛÀ» °¡´ÉÇÏ°Ô ÇÏ´Â µ¥ ÇÊ¿äÇÑ ½Ã°£°ú ºñ¿ëÀ» Àý°¨ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ ±â¼úÀº Ãʱ⠺бâÇü¿¡¼­ ¿µÀå·ù¿¡ À̸£±â±îÁö ´Ù¾çÇÑ µ¿¹°¿¡ ³Î¸® Àû¿ëµÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ Àü¿°¼º Äڷγª¹ÙÀÌ·¯½º º´(COVID-19)ÀÇ °©ÀÛ½º·± À¯ÇàÀº ½ÃÀå¿¡ À¯¸®ÇÑ Àü¸ÁÀ» °¡Á®¿Ô½À´Ï´Ù. ÀÌ´Â ¼¼°èº¸°Ç±â±¸(WHO)¿Í °°Àº ±¹Á¦±â±¸¿Í Á¤ºÎ ´ç±¹ÀÌ ¹é½Å°ú Ç×¹ÙÀÌ·¯½ºÁ¦¹°À» µµÀÔÇϱâ À§ÇÑ R&D Ȱµ¿¿¡ ´ëÇÑ ÅõÀÚ¸¦ ´Ã¸®°í Àֱ⠶§¹®ÀÔ´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

Á¦5Àå ¼¼°è µ¿¹° ¸ðµ¨ ½ÃÀå

Á¦6Àå ½ÃÀå ºÐ¼® : µ¿¹°À¯Çüº°

Á¦7Àå ½ÃÀå ºÐ¼® : ±â¼úº°

Á¦8Àå ½ÃÀå ºÐ¼® : ¿ëµµº°

Á¦9Àå ½ÃÀå ³»¿ª: ÃÖÁ¾ »ç¿ëÀÚº°

Á¦10Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦11Àå SWOT ºÐ¼®

Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦13Àå Porter's Five Forces ºÐ¼®

Á¦14Àå °¡°Ý ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global animal model market size reached US$ 1,810.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,066.0 Million by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032.

Animal models are living, non-human species used in medical research and investigations. They are frequently selected due to their vast similarities with the genetics, anatomy, and physiology of humans. They assist in obtaining information about the prevention, diagnosis, and treatment of diseases without causing harm to a human. Some of the commonly utilized animal models include rodents, rats, mice, gerbils, guinea pigs, and hamsters. At present, they are widely preferred on account of their availability, ease of handling, and relatively low cost of use.

Animal Model Market Trends:

Presently, there is a continuous increase in the need for personalized medicines across the globe. This, in confluence with a rising prevalence of genetic disorders, such as down syndrome, Crohn's disease, breast cancer, and hemophilia, represents one of the key factors positively influencing the utilization of animal models in the pre-clinical development of drugs by researchers. Apart from this, they are also being utilized in biomedical research, toxicology, physiology, cancer research, neurological research, genetic research, and xenotransplantation around the world. Furthermore, the market is propelled by numerous technological advancements, such as the introduction of CRISPR-Cas9, a genome editing technology, which aids in reducing the time and cost required for enabling the production of animal models with extensive genetic modifications. This technology finds wide applicability in a variety of animals, ranging from early-branching metazoans to primates. Besides this, the sudden outbreak of the contagious coronavirus disease (COVID-19) pandemic is creating a favorable outlook for the market. This can be accredited to the increasing investments by international organizations like World Health Organization (WHO) and government authorities in research and development (R&D) activities to introduce vaccines and antiviral drugs.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global animal model market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on animal type, technology, application, and end user.

Breakup by Animal Type:

Rat

Mice

Guinea Pigs

Rabbits

Others

Breakup by Technology:

CRISPR

Embryonic Stem Cell Injection

Nuclear Transfer

Others

Breakup by Application:

Drug Discovery and Development

Basic Research

Others

Breakup by End User:

Pharma and Biotech Companies

Academic Research Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Biocytogen, Charles River Laboratories International Inc, Envigo, Eurofins Scientific SE, GenOway S.A., Hera BioLabs, JSR Corporation, Ozgene Pty Ltd., PerkinElmer Inc., Taconic Biosciences Inc., The Jackson Laboratory and Trans Genic Inc.

Key Questions Answered in This Report:

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Animal Model Market

6 Market Breakup by Animal Type

7 Market Breakup by Technology

8 Market Breakup by Application

9 Market Breakup by End User

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

15 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â